Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data (Q33541428)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data |
scientific article |
Statements
1 reference
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data (English)
1 reference
Jürgen Schölmerich
1 reference
William J Sandborn
1 reference
Jean-Frédéric Colombel
1 reference
Stefan Schreiber
1 reference
Susanna Nikolaus
1 reference
Ralph Bloomfield
1 reference
PRECiSE 2 Study Investigators
1 reference
16 March 2010
1 reference
1 reference
105
1 reference
1574-1582
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference